Eevia Health Plc commissions new analytical equipment for analyzing anthocyanins and polyphenols

Eevia Health has commissioned a new High-Performance Liquid Chromatography (HPLC) analytical equipment from Shimadzu, which significantly increases the capacity to undertake analyses of polyphenols.

The new HPLC is a Shimadzu Nexera Lite 440 bar. It has automated sampling functionality and a huge range of specialized and advanced features, which constitutes the state of the art in liquid chromatography analytics.

The HPLC-based methods are the gold standard for analyzing anthocyanins and polyphenols. It provides not only total polyphenols but breaks them down into each specific anthocyanin. For bilberry, there are 16 recognized anthocyanins which also should appear with a certain profile to pass ID test criteria under European and US pharmacopeia monographs. 

The new HPLC from Shimadzu significantly improves the analytical capacity of Eevia and therefore enables the company to increase efforts to control the raw material Eevia purchases, internal process control, and analytics necessary for product release to the market.

"I am extremely pleased with the new HPLC. It provides a much higher capacity, significantly better specificity, and has an ease of use which is remarkable. We can now keep up with both Internal Process Control samples, as well as raw material and finished goods release jobs." says Joonas Hast, Eevia Health Lab Technician.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                          
Email: [email protected]                      
Telephone: +358 400 22 5967   


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]